Our Recent Posts

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Congrats to OrthAlign!

ltodia
Oct 2, 2017
1 min read

OrthAlign, Inc. announced it has raised $10 million in a series D financing round for product development as the company expands from a solution provider for total knee surgery to a platform technology provider for total knee, partial knee and total hip replacements, according to a company press release.

Mutual Capital Partners is proud to be a part of that financing and to see OrthAlign continue to grow!

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Congrats to OrthAlign!

Comments

©2024 by Mutual Capital Partners